Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ShenJu Granules
- Development stage
- Preclinical
- Lead developer
- Hebei Medical University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ShenJu Granules is a Traditional Chinese Medicine (TCM) formulation developed by Professor Wang Lei at Hebei Medical University/Hebei Provincial Hospital of Traditional Chinese Medicine. It is a concentrated herbal extract primarily composed of ingredients such as Ginseng (Shen) and Chrysanthemum (Ju), specifically indicated for the treatment of hyperlipidemia and carotid atherosclerosis. The drug is administered orally and is designed to improve lipid metabolism, reduce oxidative stress, and enhance vascular endothelial function. By addressing these factors, ShenJu aims to reduce arterial stiffness—evaluated through Pulse Wave Velocity (PWV)—and inhibit the progression and rupture of carotid plaques, thereby decreasing the risk of cerebrovascular events such as stroke. Compared to traditional decoctions, the granule formulation offers higher concentration, improved bioavailability, and greater patient convenience.
- Brand names
- ShenJu
- Other names
- Shenju granulesShenju formulaShen Ju Ke Li
Beyond the preview
Go deeper on ShenJu Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ShenJu Granules.